ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Novartis has received Priority Review status from Health Canada for deferasirox [Exjade]
Inpharma Weekly
◽
10.2165/00128413-200514970-00055
◽
2005
◽
Vol &NA;
(1497)
◽
pp. 22
Author(s):
&NA;
Keyword(s):
Priority Review
◽
Review Status
◽
Health Canada
Download Full-text
Related Documents
Cited By
References
131I-Tositumomab ['Bexxar'; Corixa Corporation, GlaxoSmithKline] has been granted priority review status in Canada.
Inpharma Weekly
◽
10.2165/00128413-200314040-00054
◽
2003
◽
Vol &NA;
(1404)
◽
pp. 22
Author(s):
&NA;
Keyword(s):
Priority Review
◽
Review Status
◽
131I Tositumomab
Download Full-text
Schering-Plough's temozolomide [Temodal] capsule has been granted priority review status in Japan
Inpharma Weekly
◽
10.2165/00128413-200515130-00052
◽
2005
◽
Vol &NA;
(1513)
◽
pp. 18
Author(s):
&NA;
Keyword(s):
Priority Review
◽
Review Status
Download Full-text
Letrozole [Femara; Novartis] has been granted priority review status by the US FDA
Inpharma Weekly
◽
10.2165/00128413-200515030-00055
◽
2005
◽
Vol &NA;
(1503)
◽
pp. 22
Author(s):
&NA;
Keyword(s):
Priority Review
◽
Review Status
◽
The Us
◽
Us Fda
Download Full-text
GlaxoSmithKline has been granted priority review status in Japan for adefovir dipivoxil [Hepsera; licensed from Gilead Sciences],
Inpharma Weekly
◽
10.2165/00128413-200414370-00057
◽
2004
◽
Vol &NA;
(1437)
◽
pp. 21
Author(s):
&NA;
Keyword(s):
Adefovir Dipivoxil
◽
Priority Review
◽
Review Status
Download Full-text
ISTA Pharmaceuticals' NDA* for ovine hyaluronidase ['Vitrase'] has been granted priority review status
Inpharma Weekly
◽
10.2165/00128413-200314020-00042
◽
2003
◽
Vol &NA;
(1402)
◽
pp. 18
Author(s):
&NA;
Keyword(s):
Priority Review
◽
Review Status
Download Full-text
Schering-Plough's peginterferon (PEG IFN)-??-2b plus ribavirin [Peg-Intron plus Rebetol] has been granted priority review status in Japan for a new indication,
Inpharma Weekly
◽
10.2165/00128413-200514950-00060
◽
2005
◽
Vol &NA;
(1495)
◽
pp. 23
Author(s):
&NA;
Keyword(s):
Priority Review
◽
Review Status
Download Full-text
FDA Priority Review Status to Drugs for Metastatic Breast Cancer and NSCLC
Oncology Times
◽
10.1097/01.cot.0000479767.94710.d2
◽
2016
◽
Vol 38
(1)
◽
pp. 12
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Metastatic Breast
◽
Priority Review
◽
Review Status
Download Full-text
Bristol Pharmaceutical has announced that it has been granted priority review status for entecavir [Baraclude],
Inpharma Weekly
◽
10.2165/00128413-200515140-00049
◽
2005
◽
Vol &NA;
(1514)
◽
pp. 18
Author(s):
&NA;
Keyword(s):
Priority Review
◽
Review Status
Download Full-text
FDA Priority Review Status for Defibrotide and Halaven
Oncology Times
◽
10.1097/01.cot.0000473104.86820.b7
◽
2015
◽
Vol 37
(20)
◽
pp. 17
Keyword(s):
Priority Review
◽
Review Status
Download Full-text
Health Canada's use of priority review status for drugs for unmet needs
Regulatory Toxicology and Pharmacology
◽
10.1016/j.yrtph.2015.08.002
◽
2015
◽
Vol 73
(1)
◽
pp. 391-395
◽
Cited By ~ 2
Author(s):
Nigel S.B. Rawson
Keyword(s):
Unmet Needs
◽
Priority Review
◽
Review Status
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close